AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MedservRegis Plc

Capital/Financing Update Oct 20, 2025

2071_rns_2025-10-20_7fc01685-0bbc-476c-ade2-7d49cf95e708.pdf

Capital/Financing Update

Open in Viewer

Opens in native device viewer

COMPANY ANNOUNCEMENT

MEDSERVREGIS P.L.C. (THE "COMPANY")

Issue of up to the Euro equivalent of €25,000,000 in EUR and USD unsecured Bonds due 2031 – 2036

Date of Announcement 20
October
2025
Reference 334/2025
Capital Market Rule CMR 5.16.12

Quote

Reference is made to the updates to the market provided in the company announcements issued by the Company on 16 September, 2025 (330/2025) and on 10 October, 2025 (333/2025) relative to the prospective refinancing of the combination of 5.75% USD unsecured bonds (ISIN: MT0000311242) (hereinafter, the "USD Bonds") and 4.5% EURO unsecured bonds (ISIN: MT0000311234) (hereinafter, the "EURO Bonds", which together with the USD Bonds shall hereinafter be referred to as the "2015 Bonds") issued pursuant to a prospectus dated 21 December, 2015, and the issuance by the Company of up to the Euro equivalent of €25,000,000 in 5.50% Euro (€) unsecured bonds and 6.50% US Dollar (\$) unsecured bonds due 2031 – 2036 (hereinafter, the "New Bonds").

The Board of Directors of the Company hereby announces that the Company has been granted approval by the Malta Financial Services Authority for admissibility to listing of the New Bonds on the Official List of the Malta Stock Exchange.

Full details of the New Bonds are set out in the prospectus dated 20 October, 2025 (the "Prospectus") which will be available for viewing and download from the Company's website (https://medservregis.com/investor-relations/) as from 21 October, 2025. Furthermore, copies of the Prospectus may be obtained during office hours from the Authorised Financial Intermediaries listed in annex 3 of the Prospectus as from 24 October, 2025.

In accordance with the Prospectus, interest on the New Bonds will accrue as from the date of issuance of the New Bonds, which is expected to take place on 26 November, 2025 (the "Issue Date").

The New Bonds shall be made available for subscription by holders of the 2015 Bonds as at 16 October, 2025 (last trading session being 14 October, 2025) (hereinafter, the "Existing Bondholders") by means of an exchange offer, pursuant to which said Existing Bondholders shall have the option of surrendering the 2015 Bonds held by them in favour of the Company in exchange for New Bonds of the same currency (EUR or USD, as applicable), equivalent in value to the New Bonds being applied for. Any New Bonds not subscribed for by Existing Bondholders as aforesaid may be available for subscription through an intermediaries' offer.

Applicants, being Existing Bondholders holding 2015 Bonds as at the said date and electing to subscribe for New Bonds through the exchange offer, shall: (a) relinquish their right to receive interest under the 2015 Bonds as from the Issue Date; and (b) within 30 calendar days from admission of the New Bonds to listing (the Issue Date), receive payment in respect of interest on the 2015 Bonds surrendered in favour of the Company for the period between and including 5 August, 2025 (being the most recent interest payment date on the 2015 Bonds) and the Issue Date. Thereafter, Existing Bondholders shall only be entitled to interest on the New Bonds.

Unquote

Nicola Jaccarini

Company Secretary

Talk to a Data Expert

Have a question? We'll get back to you promptly.